GlassScriptPhysician profile
Michael Levy
NPI 1699937250
$8,991.02
in general payments reported to CMS, 2019-2025
7 companies · $8,884 in 2025
The $8,884 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2025: $8,884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,750 · Travel and Lodging: $1,000 · Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,750.00 |
| Travel and Lodging | $1,000.00 |
| Food and Beverage | $133.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Koh Young America, INC. | $8,807.18 | 2025 | Geniant Cranial |
| Misonix INC | $61.34 | 2019 | |
| Karl Storz Endoscopy-America | $41.36 | 2025 | |
| Longeviti Neuro Solutions INC | $35.01 | 2025 | Clearfit |
| Integra Lifesciences Corporation | $26.01 | 2019 | |
| Analogic Corporation | $20.12 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.